Opportunity Information: Apply for PAR 24 320
The NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed) is an NIH grant opportunity from the National Cancer Institute designed to help early-career clinicians build the skills, track record, and independence needed for a long-term research career in cancer. Its central goal is career development: it provides salary support and protected time so that a clinician with a clinical doctoral degree can pursue an intensive, supervised (mentored) research and training experience. The program supports research in biomedical and behavioral science, including translational cancer research, and it is structured to move the awardee toward research independence and future competition for major NIH research grants such as the R03, R21, or R01.
A defining feature of this NCI-sponsored K08 is its focus on strengthening the cancer research workforce by supporting clinical scientists from backgrounds that have been shown to be nationally underrepresented in health-related science. The opportunity is aimed at candidates who are committed to a career in basic biomedical, behavioral, or translational cancer research, including work that addresses cancer health disparities. In practice, the expectation is that the mentored period will help the scholar deepen scientific expertise, develop strong research productivity, and assemble the preliminary data, publications, and grant-writing experience needed to successfully transition to independent funding.
This specific funding announcement is identified as PAR-24-320, offered as a discretionary grant in the Education and Health activity area (CFDA 93.398). While the award supports research career development, it explicitly does not allow clinical trials under this mechanism, meaning the proposed K08 research and training plan must fit within non-clinical-trial parameters as defined by NIH policy. The opportunity was created on 2024-12-02, and the original closing date listed is 2027-11-12.
Eligible applicant organizations span a wide range of U.S.-based entities, reflecting the fact that the award is made to an institution on behalf of the candidate. Eligible applicants include public and private institutions of higher education, independent school districts, state, county, city or township governments, special district governments, federally recognized Native American tribal governments, and Native American tribal organizations other than federally recognized tribal governments. Eligibility also includes public housing authorities/Indian housing authorities, nonprofits with and without 501(c)(3) status (other than institutions of higher education), for-profit organizations other than small businesses, small businesses, and other types of organizations. The announcement also highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments that are not federally recognized, and U.S. territories or possessions.
Foreign involvement is tightly restricted. Non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. In short, the program is meant to build U.S.-based mentored career development capacity in cancer research while expanding participation among groups that have been historically underrepresented in the health research enterprise.Apply for PAR 24 320
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
- This funding opportunity was created on 2024-12-02.
- Applicants must submit their applications by 2027-11-12.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): NCI CURE Mentored Clinical Scientist Research Career Development Award (K08, Clinical Trial Not Allowed) - PAR-24-320
1) What is this funding opportunity?
This opportunity is the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed). It is an NIH grant opportunity from the National Cancer Institute (NCI) designed to support early-career clinicians as they build the skills, research record, and trajectory needed for a long-term, independent cancer research career.
2) What is the main purpose of the NCI CURE K08?
The central purpose is career development. The award provides salary support and protected time so a clinician with a clinical doctoral degree can complete an intensive, supervised (mentored) research and training experience. The structure is intended to move the awardee toward research independence and future competition for larger NIH research grants (for example, R03, R21, or R01).
3) What kind of research areas does this K08 support?
The program supports research in biomedical and behavioral science, including translational cancer research. It also includes work that addresses cancer health disparities, consistent with the program's stated emphasis on strengthening and diversifying the cancer research workforce.
4) Who is this award designed to support?
This NCI-sponsored K08 is aimed at early-career clinicians who are committed to a career in basic biomedical, behavioral, or translational cancer research. A defining feature is its focus on supporting clinical scientists from backgrounds that have been shown to be nationally underrepresented in health-related science.
5) What does "mentored" mean in this program?
The award supports an intensive, supervised research and training experience. The expectation is that during the mentored period, the scholar will deepen scientific expertise, build research productivity, and develop the publications, preliminary data, and grant-writing experience needed to transition to independent research funding.
6) Is the award intended to lead to future NIH funding?
Yes. The opportunity is structured to move the awardee toward research independence and to strengthen competitiveness for major NIH research grants, specifically noting examples such as the R03, R21, or R01.
7) Are clinical trials allowed under this K08?
No. This funding announcement explicitly states "Clinical Trial Not Allowed." The proposed K08 research and training plan must fit within non-clinical-trial parameters as defined by NIH policy.
8) What is the funding announcement number for this opportunity?
The funding announcement is identified as PAR-24-320.
9) Which federal agency is offering this grant?
The opportunity is offered through the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI).
10) What type of grant is this categorized as?
It is described as a discretionary grant in the Education and Health activity area.
11) What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.398.
12) When was this opportunity created and what is the closing date listed?
The opportunity was created on 2024-12-02. The original closing date listed is 2027-11-12.
13) Who applies for the award: the individual or the organization?
The award is made to an institution on behalf of the candidate. In other words, the applicant organization submits the application to support the clinician candidate's mentored career development program.
14) What types of U.S. organizations are eligible to apply?
Eligible applicants span a wide range of U.S.-based entities, including:
- Public and private institutions of higher education
- Independent school districts
- State, county, city, or township governments
- Special district governments
- Federally recognized Native American tribal governments
- Native American tribal organizations (other than federally recognized tribal governments)
- Public housing authorities/Indian housing authorities
- Nonprofits with and without 501(c)(3) status (other than institutions of higher education)
- For-profit organizations other than small businesses
- Small businesses
- Other types of organizations
15) Are minority-serving institutions specifically included as eligible applicants?
Yes. The announcement highlights additional eligible applicant types, including:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-serving institutions
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
16) Are faith-based or community-based organizations eligible to apply?
Yes. The eligible applicant list includes faith-based or community-based organizations.
17) Are federal agencies eligible to apply?
Yes. The announcement lists eligible federal agencies among eligible applicant types.
18) Are U.S. territories or possessions eligible to apply?
Yes. The eligible applicant types include U.S. territories or possessions.
19) Can non-U.S. (foreign) organizations apply?
No. Non-domestic (non-U.S.) entities are not eligible to apply.
20) Can a U.S. organization apply if the work will be performed at a non-U.S. component?
No. Non-domestic components of U.S. organizations are not eligible to apply.
21) Are foreign components allowed in any form?
No. Foreign components (as defined by the NIH Grants Policy Statement) are not allowed.
22) Why does this program emphasize underrepresented backgrounds in health-related science?
A defining feature of this NCI-sponsored K08 is its goal of strengthening the cancer research workforce by supporting clinical scientists from backgrounds that have been shown to be nationally underrepresented in health-related science, while building U.S.-based mentored career development capacity in cancer research.
23) Is the program relevant to researchers focused on cancer health disparities?
Yes. The opportunity explicitly includes translational cancer research and notes that it includes work addressing cancer health disparities.
24) What outcomes are expected from the mentored period?
The description emphasizes outcomes that position the scholar for independence, including deeper scientific expertise, strong research productivity, preliminary data, publications, and experience with grant writing to support a transition to independent funding.
Browse more opportunities from the same category: Education, Health
Next opportunity: FY25 IIJA/IRA Bureau of Land Management Oregon/Washington (ORWA) Forest and Woodlands Resource Management
Previous opportunity: Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 24 320
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 24 320) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required) Apply for RFA DA 26 004 Funding Number: RFA DA 26 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required) Apply for RFA DA 26 003 Funding Number: RFA DA 26 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) Apply for PAR 25 299 Funding Number: PAR 25 299 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) Apply for RFA DA 26 056 Funding Number: RFA DA 26 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) Apply for RFA DA 26 055 Funding Number: RFA DA 26 055 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) Apply for PAR 25 100 Funding Number: PAR 25 100 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) Apply for PAR 24 330 Funding Number: PAR 24 330 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) Apply for RFA HG 25 007 Funding Number: RFA HG 25 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Apply for PAR 25 321 Funding Number: PAR 25 321 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Apply for PAR 25 346 Funding Number: PAR 25 346 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) Apply for RFA AA 24 012 Funding Number: RFA AA 24 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) Apply for PAR 25 317 Funding Number: PAR 25 317 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Apply for PAR 25 325 Funding Number: PAR 25 325 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) Apply for PAS 25 236 Funding Number: PAS 25 236 Agency: National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 25 003 Funding Number: RFA CA 25 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 25 001 Funding Number: RFA CA 25 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 25 004 Funding Number: RFA CA 25 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 25 002 Funding Number: RFA CA 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) Apply for PAR 25 336 Funding Number: PAR 25 336 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional) Apply for RFA CA 25 019 Funding Number: RFA CA 25 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 24 320", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.